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ABSTRACT 
Oxidative stress is associated with the generation of excess free radicals and reduction in the levels of antioxidant enzymes. It is 
also implicated in the initiation and progression of colorectal cancer. Cymbopogon citratus, commonly called ‘lemon grass,’ is 
widely distributed in the tropics and it is known for its therapeutic applications. In this study, the antioxidant activities of the 
crude ethanol extract of Cymbopogon citratus and its fractions were determined using total antioxidant capacity (TAC), 2-2-
diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, Fe3+ reducing ability, total phenolic content (TPC) and total 
flavonoid content (TFC). The phytocomponents were determined through Gas Chromatography - Mass Spectrometry and lipid 
peroxidation was induced in rat colon homogenate. TFC and TPC were highest in the ethyl acetate fraction (EAF) > crude extract 
(CE) > ethanol fraction (EF) > chloroform fraction (CF). Both DPPH scavenging activity and Fe3+ reducing ability exhibited 
similar trend; EAF > EF > CF > CE. In addition, the ability to inhibit lipid peroxidation in rat colon is as follows; EAF> CF > 
CE > EF. The EAF and CF of the ethanol extract of C. citratus contain most of the compounds that could be responsible for its 
activity against reactive oxygen species. 
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Oxidative stress is associated with the generation of excess 
free radicals and reduction in the levels of antioxidant 
enzymes, and it is also implicated in the initiation and 
progression of colorectal cancer (Skrzydlewska et al., 2005). 
Reactive oxygen species (ROS) are able to oxidise 
polyunsaturated fatty acid components of the cell membrane 
thereby initiating lipid peroxidation (Perse 2013). This chain 
of reactions will generate lipid peroxidation products, some of 
which are also free radicals. These products include 
malondialdehyde (MDA), hydroperoxides, conjugated dienes, 
lipoperoxides and toxic aldehydes (Perse 2013). When 
products of lipid peroxidation, particularly MDA and 4-
hydroxy-2-nonenal (4-HNE), are produced in excess, they 
may react with DNA bases to form etheno-DNA adducts that 
are mutagenic and have been reported to contribute to the 
initiation of colorectal cancer (Obtulowics et al., 2010). 
Malondialdehyde, which is a mutagenic agent in bacterial and 
mammalian systems, reacts with DNA to form adducts with 
deoxyguanosine, deoxycytidine, and deoxyadenosine 
(Leuratti et al., 2002). Oxidative stress has been implicated in 
the initiation and progression of colorectal cancer with 
increase in products of lipid peroxidation in this cancer type. 
A significant increase in the level of MDA and 4-HNE in 
primary colorectal tumour compared to normal colon has also 
been reported (Skrzydlewska et al., 2005). Previous works 
have reported as increase in plasma and tissue concentrations 
of MDA in colorectal cancer patients (Hendrickse et al., 
1994). Such increase can lead to DNA damage and / or reduce 
 
www.ajbrui.org 
Antioxidant capacities and phytoconstituents of Cymbopogon citratus 
430 Afr. J. Biomed. Res. Vol. 23, No.3 (September) 2020  Karigidi et al 
DNA repair in affected tissues including the colon which can 
eventually results in colon cancer.  
 According to Global Cancer Statistics report in 2018, 
colorectal cancer had the third highest number of new cases 
(10.2%) and the second highest number of deaths (9.2%) after 
lung cancer (18.4%) (Bray et al., 2018). The incidence of 
colon cancer in sub-Saharan Africa is estimated at above 4 
persons per 100,000 populations (Irabor 2017). In Nigeria, its 
incidence has been estimated at more than 3 persons in every 
100,000 population (Irabor et al., 2014) rising from 21 patients 
per year between 1954 -1967 to 70 patients per year between 
year 2000 and 2006 (Irabor, 2017).  
 Cymbopogon citratus (DC.) stapf (lemongrass) is an 
economically important aromatic plant majorly cultivated for 
its medicinal uses in some parts of Asia, America and Africa. 
In Nigeria, it is used to treat stomach upset, fever, malaria and 
as an antioxidant tea (Avoseh et al., 2015).  In India, hot water 
extract of dried C. citratus is used for bathing in cases of fever 
and headache (John, 1984; Rao et al., 1982), while in Malaysia 
and Indonesia, hot water extract of the plant is taken orally for 
its anti-hypertensive and anti-obesity properties (Olorunnisola 
et al., 2014). Furthermore, in Thailand, hot water extract of its 
dried roots is used to treat diabetes (Mueller-Oerlinghausen et 
al., 1971). Ethanol extract of C. citratus has been reported to 
possess antimutagenic activities (Vinitketkumnuen et al., 
1994; Meevatee et al., 1993) and its fresh leaf aqueous extract 
has been demonstrated to possess hypolipidemic and 
hypoglycaemic activities in rats (Adeneye et al., 2007). The 
essential oil of C. citratus has also been shown to possess both 
antioxidant and antibacterial properties (Olaiya et al., 2016).  
 Considering the human exposure to the extract of this 
plant, the possible effect on the colon, and the limited 
information about the role of ethanol extract of C. citratus and 
its fractions on the inhibition of Fe2+-induced lipid 
peroxidation in rat colon, the solvent fractions of the ethanol 
extract of C. citratus and the phytocomposition were 
determined while the effect of the solvent fractions on lipid 
peroxidation in rat colon was assessed.  
 
 
MATERIALS AND METHODS 
 
Chemicals and reagents: Ascorbic acid, sodium carbonate, 
2-2-diphenyl-1-picrylhydrazyl (DPPH), gallic acid, quercetin, 
trichloroacetic acid (TCA) and thiobarbituric acid (TBA) were 
bought from Sigma-Aldrich, St Louis, USA while Folin-
Ciocalteu reagent, sodium hydroxide, aluminium chloride and 
other chemicals were purchased from Loba Chemie, India. All 
other chemicals used for this study were of analytical grade.  
 
Plant material: Cymbopogon citratus (lemongrass) was 
harvested from a lemongrass farm in Lagelu Local 
Government Area, Ibadan, Oyo state, Nigeria. It was 
identified, authenticated and sample specimen deposited at the 
herbarium of the Department of Botany, University of Ibadan, 
Ibadan with voucher number UIH 22637. The leaves were cut 
into small pieces, washed in clean water and air-dried. The 




Six Wistar rats (100-120 g) were purchased from the Central 
Animal House of the Preclinical Departments, University of 
Ibadan, Ibadan. Food and water were given ad libitum.  
 
Plant Extraction and Fractionation 
Two kilogrammes (2 kg) of powdered leaf of C. citratus were 
extracted with 25 litres of 80% ethanol for 72 hours with 
intermittent stirring, and filtered with a muslin cloth. Further 
filtration was carried out using Whatman No 1 filter paper. 
The filtrate obtained was then concentrated using a rotary 
evaporator. Subsequently, fractionation of concentrated 
extract of C. citratus was carried out as earlier described by 
Seelinger et al. (2012). One hundred and twenty grammes 
(120 g) of the crude extract was re-dissolved in 80% ethanol 
and absorbed with silica gel (ratio 1:2). The mixture was 
allowed to dry for 2 days after which it was ground to form a 
homogenous mixture that was loaded on a silica gel-packed 
Buchner funnel. The packed funnel was eluted with three 
solvents in order of increasing polarity; chloroform, ethyl 
acetate and ethanol under pressure. The eluted portions were 
concentrated in a rotary evaporator to form chloroform, ethyl 
acetate and ethanol fractions respectively. 
 
Percentage yield of crude extract =    
Final weight of crude extract  x 100 
Initial weight of dried sample 
Percentage yield = 6.28%    
  
 
Phytochemical screening:  
Screening for phytochemicals in the three fractions and crude 
extract of C. citratus obtained was carried out as earlier 
described (Sofowora, 1993). 
 
Total phenolic content: Total phenolic content for each of the 
three fractions and crude extract was determined 
spectrophotometrically according to the method of Kim et al. 
(2006). Total phenolic content was calculated from a gallic 
acid standard curve and expressed as gallic acid equivalent 
(GAE). 
 
Total flavonoid content: Total flavonoid content (TFC) of 
crude extract and its three fractions was determined 
spectrophotometrically as earlier done by Zhisten et al. (1999) 
and modified by Talukdar (2013). The TFC was calculated 
from quercetin standard curve and expressed as quercetin 
equivalent (QUE) 
 
Antioxidant and free radical scavenging assays 
 
Total antioxidant capacity: Total antioxidant capacity (TAC) 
was measured according to Prieto et al. (1999). The TAC was 
estimated from ascorbic acid standard curve and expressed as 
ascorbic acid equivalent (AAE). 
 
Reducing power capacity: The reducing power capacity of the 
fractions and crude extract was evaluated as earlier described 
by Oyaizu (1986). Ascorbic acid was used as standard. 
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DPPH radical scavenging activity: DPPH scavenging 
activity of the fractions was determined following the method 
of Gyamfi et al. (1999). Ascorbic acid was used as the 
reference compound. Percentage inhibition was calculated as: 
 
% inhibition of DPPH =  
Absorbance of control – Absorbance of sample   x 100 




Tissue homogenate preparation:  
The rats were euthanised with sodium pentobarbitone and 
dissected, the colon was quickly harvested, placed on ice and 
weighed. Subsequently, the tissue was homogenised in cold 
normal saline (1:4 w/v). The homogenate was centrifuged for 
10 minutes at 3000 rpm and the supernatant (rich in lipid) was 
used for lipid peroxidation inhibition assay.  
 
Lipid peroxidation inhibition assay:  
Determination of the lipid peroxidation inhibition activity of 
chloroform fraction, ethyl acetate, ethanol fraction and crude 
extract of C. citratus was carried out following the method of 
Ohkawa et al. (1979) with slight modification. Colon 
homogenate (100 µL) was mixed with 30 µL of 0.1 M Tris-
HCl buffer (pH 7.4) and 100 µL of each fraction, 30 µL of 25 
µML-1 of freshly prepared ferric sulphate, a pro-oxidant 
solution. The mixture was incubated for two hours at 37 oC. 
Chromophore was developed when 300 µL of sodium 
dodecylsulphate (SDS) was added followed by 600 µL of 
0.8% TBA. The final mixture was incubated at 100 oC for 1 
hour. The absorbance of adduct of TBA- malondialdehyde 
(MDA) formed was measured at 532 nm. Malondialdehyde 
produced was expressed as percentage of the control. 
 
Gas chromatography- mass spectrometry (GC-MS) 
Gas chromatography-mass spectrometry was carried out 
according to the method of Sermakkani et al. (2012). 
Identification of components was determined by their 
molecular structure and mass. The spectral peaks obtained 
were compared with mass spectra database of National 
Institute of Standards and Technology (NIST).  
 
Statistical analysis 
Data in this study were expressed as mean + SD of three 
measurements. The mean values were compared using one-
way ANOVA (P < 0.05) and the graphs were constructed with 





The phytochemical screening of the crude extract and 
fractions indicates the presence of flavonoids, terpenoids, 
saponins and alkaloids while steroids are present in all except 
ethyl acetate fraction (Table 1).  
 The total phenolic and flavonoid contents are highest in 
ethyl acetate fraction and the trend is: EAF > CE > EF > CF 
(Figure 1a and b). However, the TAC of CF and EAF are not 
significantly different (P < 0.05) from each other although 
both are higher and significantly different from the TAC of EF 
and CE (Figure 1c). The crude extract and fractions exhibit a 
concentration-dependent increase in reducing power activity. 
Ethyl acetate fraction has the highest ability to reduce 
Fe3+/ferricyanide complex to ferrous iron (Fe2+) while the 
crude extract has the least ability at the highest concentration 
(Figure 1e).  
 The DPPH free radical scavenging activity follow the 
same trend as reducing power activity with the EAF having 
the highest activity as shown in figure 1d. The scavenging 
activities are as follow: EF > CF > CE. This is evident in the 
medial inhibitory concentration (IC50) values of EAF (0.22 + 
0.02 mg/mL), EF (0.69 + 0.06 mg/mL), CF (0.70 + 0.02 
mg/mL) and CE (1.40 + 0.04 mg/mL) (Table 2). 
 
 
Table 1:  











Flavonoids Present Present Present Present 
Saponins Present Present Present Present 
Steroids Present Absent Present Present 
Terpenoids Present Present Present Present 
Alkaloids Present Present Present Present 
 
 
Table 2:  
IC50 (mg/mL) of fractions and crude extract of ethanol extract of C. 
citratus on DPPH radical scavenging activity and MDA production 
inhibition. 






Chloroform fraction 0.70 + 0.02a 0.52 + 0.04b 
Ethyl acetate 
fraction 
0.22 + 0.02b 0.48 + 0.01a 
Ethanol fraction 0.69 + 0.06a 0.76 + 0.02b 
Crude extract 1.40 + 0.04c 0.32 + 0.25c 
 
Furthermore, the crude extract and fractions inhibit the 
production of malondialdehyde (MDA) induced by ferric 
sulphate (a prooxidant) in the rat colon homogenate in a dose-
dependent manner. The trend of the activities is as follows: 
EAF > CF > CE > EF at their highest concentrations (Figure 
1f). As shown in Table 2, the IC50 values of CE, EAF, CF, and 
EF are 0.32 + 0.25 mg/mL, 0.48 + 0.01 mg/mL, 0.52 + 0.04 
mg/mL, and 0.76 + 0.02 mg/mL, respectively. Overall, EAF 
shows the highest MDA activity in rat colon homogenate. 
 The GC-MS analysis of CF, EAF and EF reveal the 
presence of fourteen, seven and seven phytocompounds, 
respectively while that of CE reveal the presence of twenty-
two phytocompounds. The activities of the phytoconstituents 
are responsible for the medicinal property of both fractions 
and crude extract in the inhibition of MDA production (Figure 
2; Tables 3 - 6).  
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Figure 1:  
Results on assays on crude extract and fractions of C. citratus. (a) Total phenolic content (b) Total flavonoid content (c) Total antioxidant 
capacity (d) 2-2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity (e) Reducing power ability. (f) Inhibition of malondialdehyde    
production in rat colon homogenate. Values were presented as mean + SD of triplicate readings. Bars with different letters (a,b,c) down each 
row are significantly different (p < 0.05). 













Figure 2:  
Mass spectra and structure of phytocompounds identified by GC-MS in C. citratus. (a) crude extract (b) chloroform fraction (c) ethyl acetate 
fraction (d) ethanol fraction. 
 
Table 3:  
GC-MS analysis of the phytoconstituents of chloroform fraction of C. citratus
S/No R/T Compound name Molecular formula Molecular weight Peak Area (%) 
1 11.62 2,6-Octadienoic acid, 3,7-dimethyl -, (E)- C10H16O2 168 19.44 
2 13.60 Acetaminophen C8H9NO2 151 10.74 
3 13.91 3-Tridecanol                         C13H28O 200 3.97 
4 13.99 2-Cyclohexen-1-one, 3,5-dimethyl-    C8H12O 124 4.80 
5 14.03 Carbonic acid, 2-methoxyethyl cyclohexylester C12H24O4 232 3.38 
6 14.47 2-Propanone, 1-cyclopentyl-Diethylsilane            C8H14O 126 6.06 
7 14.58 2,3-Pentadienoic acid-, 2-ethyl-4-phenyl-,ethylester C15H18O2 230 6.15 
8 14.70 Furan, 2,5-dimethyl-                  C6H8O 96 13.01 
9 19.22 Orcinol C7H8O2 124 2.98 
10 20.12 Neophytadiene C20H38 278 2.28 
11 21.90 Pentadecanoic acid, 14-methyl-,methyl ester C17H34O2 270 6.39 
12 25.45 9,12-Octadecadienoic acid, methylester C19H34O2 294 8.39 
13 25.59 9,12,15-Octadecatrien-1-ol, (Z,Z,Z) C18H32O 264 6.42 
14 25.80 Phytol C20H40O 296 5.99 
(mainlib) 9,12,15-Octadecatrien-1-ol, (Z,Z,Z)-
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(mainlib) Hexadecanoic acid, methyl ester




























































(mainlib) Pentadecanoic acid, methyl ester
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(mainlib) 1,6-Octadiene, 3,7-dimethyl-, (S)-
















(mainlib) 2,6-Octadienoic acid, 3,7-dimethyl-, (E)-
















































































(mainlib) 2,6-Octadienoic acid, 3,7-dimethyl-, (E)-








































(mainlib) Hexadecanoic acid, methyl ester
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(mainlib) 9-Octadecenoic acid (Z)-, methyl ester

































































(mainlib) 9-Hexadecenoic acid, methyl ester, (Z)-

























(mainlib) Pentadecanoic acid, 13-methyl-, methyl ester






















(mainlib) Pentadecanoic acid, 13-methyl-, methyl ester






















(mainlib) 12-Octadecenoic acid, methyl ester
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(mainlib) Carbonic acid, 2-methoxyethyl 2-ethylhexyl ester


























































(mainlib) 2,3-Pentadienoic acid, 2-ethyl-4-phenyl-, ethyl ester




























Table 4:  
GC-MS analysis of the phytoconstituents of ethyl acetate fraction of C. citratus. 






1 8.98 Benzofuran, 2,3-dihydro-              C8H8O 120 19.49 
2 10.78 2-Methoxy-4-vinylphenol              C9H10O2 150 6.36 
3 11.46 2,6-Octadienoic acid, 3,7-dimethyl -, (E)- C10H16O2 168 11.23 
4 14.41 1-(2-Methoxy-4-methyl-cyclohex-3-enyl)-1-methyl-ethylamine C12H25O 183 9.74 
5 21.90 Hexadecanoic acid, methyl ester     C17H34O2 270 19.31 
6 25.45 9,12-Octadecadienoic acid, methyl ester, (E,E)- C19H34O2 294 18.09 
7 25.60 9-Octadecenoic acid (Z)-, methyl ester C19H36O2 296 15.78 
Table 5:  
GC-MS analysis of the phytoconstituents of ethanol fraction of C. citratus. 
S/No. RT Compound name Molecular formula Molecular weight Peak Area (%) 
1 17.91 Methyl tetradecanoate               C15H30O2 242 0.96 
2 21.47 9-Hexadecenoic acid, methyl ester, (Z)- C17H32O2 268 0.81 
3 22.06 Pentadecanoic acid, 14-methyl-, methyl ester C17H34O2 270 27.23 
4 25.61 9,12-Octadecadienoic acid, methyl ester C19H34O2 294 21.78 
5 25.87 12-Octadecenoic acid, methyl ester C19H36O2 296 0.53 
6 26.24 Methyl stearate    C19H38O2 298 2.38 
7 31.80 6-Nonenal, 3,7-dimethyl-             C11H20O 168 0.33 
Table 6:  
GC-MS analysis of the phytoconstituents of crude extract of C. citratus. 
S/No. RT Compound name Molecular formula Molecular weight Peak Area (%) 
1 4.85 1,6-Dimethylhepta-1,3,5-triene       C9H14 122 0.68 
2 8.98 Benzaldehyde, 2-methyl-               C8H8O 120 3.85 
3 11.25 Geranic acid C10H16O2 168 1.24 
4 12.19 2,6-Octadienoic acid, 3,7-dimethyl-, (E)- C10H16O2 168 48.45 
5 13.60 1,6-Octadiene, 3,7-dimethyl-, (S)-   C10H18 138 1.57 
6 13.67 2-Methyl-5-(fur-3-yl)-pent-3-en-2-ol C10H14O2 166 1.47 
7 14.02 2-Cyclohexen-1-one, 3,5-dimethyl-    C8H12O 124 4.50 
8 14.13 Methylphosphonic acid CH5O3P 96 1.96 
9 14.55 2-Propanone, 1-cyclopentyl-          C8H14O 126 4.22 
10 14.64 3-Buten-1-ol, 3-methyl-2-methylene    C6H10O 98 2.37 
11 14.74 2-Furanmethanamine                    C5H5O2 97 4.64 
12 18.22 (E)-4-(3-Hydroxyprop-1-en-1-yl)-2-methoxyphenol 
(trans- Sinapyl alcohol) 
C10H12O3 210 1.53 
13 19.25 5,5,8a-Trimethyl-3,5,6,7,8,8a-hexahydro-2H-
chromene 
C12H20O 180 1.35 
14 21.90 Pentadecanoic acid, methyl ester C16H32O2 256 1.36 
15 22.79 n-Hexadecanoic acid                 C16H32O2 256 2.18 
16 25.82 Phytol C20H40O 296 3.10 
17 27.02 9,12,15-Octadecatrien-1-ol, (Z,Z,Z) C18H32O 264 1.40 





Various natural products derived from plants have been 
reported to possess biological activities both in in vitro and in 
vivo models (Gbadegesin et al., 2017; Olugbami et al., 2017; 
Olugbami et al., 2020). For instance, the ability of some 
natural products, such as phytochemicals, to scavenge free 
radicals and ROS both in vitro/in vivo have been well-
documented (Adebooye et al., 2008; Hazra et al., 2010; 
Olugbami et al., 2015).  Free radicals and ROS are involved 
in the aetiology of several diseases including colon cancer. 
However, some plant-derived antioxidants are capable of 
preventing the adverse effects associated with chemotherapy, 
radiotherapy and immunotherapy (Roy et al., 2018). Ethanol 
extract of C. citratus has been reported in a previous study to 
inhibit the formation of DNA-adduct induced by 
azoxymethane in the colon of rat (Suaeyun et al., 1997). 
Hence, this present study was designed to investigate the 
bioactivity of this extract and some of its fractions, namely: 
chloroform, ethyl acetate and ethanol fractions.  
 From the phytochemical screening, flavonoids and 
phenolics are present in the crude extract and all fractions. 
These phytochemicals could be responsible for their 
antioxidant activities. Basically, flavonoids are a class of plant 
secondary metabolites which possesses the ability to chelate 
metals, prevent lipid peroxidation and attenuate activities of 
ROS (Heim et al., 2002). Other mechanisms that explain the 
antioxidant capacity of phenolics are the ability to bind metal 
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ions, prevent substrate oxidation and intercepting singlet 
oxygen (Halliwell et al., 1998). Flavonoids and other 
phenolics have been reported to be useful for pharmaceutical 
and medical purposes (Tungnunnithum et al., 2018). Some 
other studies have linked the flavonoid and phenolic 
constituents of plants with potent antioxidant property to the 
lowering of the incidence of several diseases including cancer 
(Adebooye et al., 2008; Aryal et al., 2019). More so, phenolic 
compounds have long been reported as chemopreventive 
agents (Ahmed et al., 2016; Mishra et al., 2013). 
 The GC-MS analyses of the crude extract and its fractions 
indicate the presence of hydroxyl groups in the structures of 
their phytocomponents. The EAF, which possesses the highest 
TFC, TPC and TAC, also displays the highest ability to inhibit 
MDA production in rat colon homogenate in a concentration-
dependent manner, is followed closely by CF. A previous 
report has associated stronger antioxidant capacity of plant 
materials with higher flavonoid and phenolic contents (Shi et 
al., 2018). The ethyl acetate fraction and chloroform fraction 
contain most of the compounds that could be responsible for 
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